The shares were sold at $23.72 average price, making the total transaction around $210,057. Mr. Burstein now directly owns 17,284 of the company’s stock, valued at around $410,149. The day after the sale, Exactech shares traded down 0.80 percent during mid-day trading.
The company’s stock opened at $23.57 on Aug. 27 with a market cap at $324.59 million. The company’s 52-week low was $18.34 and high was $26.52. Recently, the company reported Jeffrey Pierson, MD, implanted its first Alteon Tapered Wedge Femoral Stem.
In the second quarter, the company reported $4.2 million in net income, which increased significantly over last year. Revenue was up 6 percent to $62.9 million. However, the company’s spine and biologic revenue decreased 5 percent. Gross margins increased to 69.4.
Earlier in the summer, Executive Vice President sold more than 12,000 shares of the company, then sold another 16,000 shares a few weeks later.
More articles on orthopedic devices:
Amedica names Dr. B. Sonny Bal chairman of the board
8 predictions on the advanced orthopedic technologies market through 2019
French surgeon performs first spine surgery using Expanding Orthopedics’ FLXfit
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
